Inspira Technologies' Innovations in Life-Support Systems
Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) is at the forefront of healthcare technology with its groundbreaking INSPIRA™ ART100 system. This life-support system, which has received FDA clearance, is set to be a highlight at the upcoming AmSECT 63rd International Conference. This premier event for perfusion professionals will serve as a platform for showcasing advanced techniques in cardiopulmonary bypass procedures.
Overview of the AmSECT Conference
The American Society of ExtraCorporeal Technology (AmSECT) International Conference is renowned globally for its focus on the latest advancements in extracorporeal circulation and perfusion technology. Attendees will have the invaluable opportunity to witness not only the INSPIRA ART100 in action, but also to engage with leading industry experts.
What to Expect at the Conference
Glo-Med Networks Inc., the trusted distributor for Inspira Technologies, will host a booth where attendees can learn all about the INSPIRA ART100 system. This innovative technology is designed to enhance the efficiency of cardiopulmonary bypass procedures, marking a significant leap forward in patient management during surgeries.
Insights from the CEO
Dagi Ben-Noon, the Chief Executive Officer of Inspira Technologies, expressed enthusiasm regarding the conference. He highlighted the event as a key opportunity for the company to demonstrate how the INSPIRA ART100 system can transform the practices of perfusion professionals. The collaborative atmosphere allows for sharing insights that could ultimately benefit patient care.
Networking Opportunities
Those attending the conference are encouraged to schedule meetings to discuss the potential applications of Inspira's technologies. For interested individuals, they can connect directly with Levi Perryman, who is available for personal discussions at the event.
About the INSPIRA ART100 System
The INSPIRA ART100’s recent FDA 510(k) clearance further validates its position as a pioneering solution in medical technology. Designed to support cardiopulmonary bypass procedures, this system enhances patient care and operational efficiency within surgical settings. Its features are reflective of Inspira’s commitment to providing state-of-the-art life-support technologies that prioritize patient safety and improved outcomes.
Inspira Technologies' Vision
Inspira Technologies is not only advancing the field with the INSPIRA ART100 but is also working on other innovations, including the INSPIRA ART500 system, aimed at revolutionizing critical care. The goal is to allow patients to stay awake during treatment while stabilizing their oxygen levels without resorting to mechanical ventilation.
Future Developments
In addition to its current offerings, Inspira Technologies is in the process of developing cutting-edge technologies like the HYLA blood sensor, which enables continuous and real-time blood monitoring without the need for invasive procedures. Such innovations signify Inspira’s dedication to patient-centric solutions and the enhancement of modern medical practices.
Frequently Asked Questions
What is the INSPIRA ART100 system?
The INSPIRA ART100 system is an FDA-cleared life-support technology designed for cardiopulmonary bypass procedures.
Where will the AmSECT conference take place?
The AmSECT 63rd International Conference will be held at the Loews Coronado Bay Resort.
How can I connect with Inspira Technologies at the event?
You can connect with Levi Perryman to schedule a meeting at the conference.
What other technologies is Inspira Technologies developing?
Inspira is also developing the INSPIRA ART500 system and the HYLA blood sensor for enhanced patient care.
Why is the AmSECT conference significant?
The AmSECT conference is significant for sharing knowledge and advancements in extracorporeal circulation and perfusion technology among professionals.
